A Study to Assess the Feasibility of Folate Scan in Patients with Idiopathic Pulmonary Fibrosis
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-002674
Sponsor Protocol Number: 16-002674
About this study
The purpose of this study is to assess the feasibility of Folate scan in patients with Idiopathic Pulmonary Fibrosis (IPF).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Clinical/Radiological/Pathological diagnosis of IPF
- Signed informed consent
- Age >= 18 years
- Not required: Scheduled to undergo or recently underwent diagnostic lung biopsy or scheduled for lung transplantation (we will preferentially invite patients to participate in this study if they are scheduled to undergo a clinically indicated lung biopsy or lung transplantation)
Exclusion Criteria
- Immunosuppressive therapy (> 5 mg/day of Prednisone or inhaled corticosteroids)
- Pregnancy or breast feeding
- Subject is mentally incapable of understanding study procedures.
- Patient is unable to tolerate the conditions for radionuclide imaging
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Tobias Peikert, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available